SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-013600
Filing Date
2021-03-16
Accepted
2021-03-16 16:30:40
Documents
3
Period of Report
2021-03-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K itrm-8k_20210311.htm 8-K 39139
2 EX-10.1 itrm-ex101_7.htm EX-10.1 43713
3 EX-99.1 itrm-ex991_6.htm EX-99.1 12069
  Complete submission text file 0001564590-21-013600.txt   96283
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 21746192
SIC: 2834 Pharmaceutical Preparations